Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage TNBC By Ogkologos - November 21, 2024 530 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BELLINI study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer ESMO Calls for Robust EU Taxation of Tobacco Products, Aiming to Prevent Cancers Attributable to Tobacco Use EMA Recommends Granting a Marketing Authorisation for Biosimilar Pegfilgrastim MOST POPULAR Withdrawal of the Application to Change the EMA Marketing Authorisation for... December 2, 2022 New study to investigate breast cancer in ethnic minority groups July 11, 2023 How My Cancer Diagnosis at Age 17 Changed My Perspective on... December 14, 2020 Scientists uncover how incurable skin cancer resists treatment at the end... March 29, 2023 Load more HOT NEWS Olanzapine Reduces Nausea and Vomiting Caused by Advanced Cancer Immunotherapy Prolongs Survival in Recurrent, Persistent or Metastatic Cervical Cancer [ESMO... Relugolix Approval Expected to Alter Treatment for Advanced Prostate Cancer Dr Ian Walker on Smoking: ‘An unequal burden, but a fixable...
